Skip to main content

Melanoma and skin cancers: Targeted therapy

Journal articles and book chapters

09-10-2017 | Dabrafenib | Article

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib

Long G et al. J Clin Oncol 2018; 36(7): 667-673. doi:10.1200/JCO.2017.74

06-03-2017 | Melanoma | Article

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

Dummer R et al. Lancet Oncol 2017; 18(4): 435-445. doi:10.1016/S1470-2045(17)30180-8

01-09-2016 | Non-melanoma skin cancer | Article

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials

Chang ALS et al. Orphanet J Rare Dis 2016; 11: 120. doi:10.1186/s13023-016-0506-z

04-06-2016 | Non-melanoma skin cancer | Article

Management of high-risk squamous cell carcinoma of the skin

Fu T, Aasi SZ, & Hollmig ST. Curr Treat Options in Oncol 2016; 17: 34. doi:10.1007/s11864-016-0408-2

03-02-2015 | Basal cell carcinoma | Article

Management of high-risk and advanced basal cell carcinoma

An expert review of the management recommendations for high-risk and advanced basal cell carcinoma including surgical excision, Mohs micrographic surgery, radiotherapy, and novel agents in development.

Puig S |& Berrocal A. Clin Transl Oncol 2015; 17: 497–503. doi:10.1007/s12094-014-1272-9

01-01-2015 | Non-melanoma skin cancer | Article

Non-melanoma skin cancer: primary non-surgical therapies and prevention strategies

In this chapter the authors present non-surgical treatment options for the two most common non-melanoma skin cancers basal cell and squamous cell carcinoma.

Buchanan MA et al. In: Non-melanoma Skin Cancer of the Head and Neck. Edited by F Riffat, CE Palme, M Veness. India: Springer India, 2015. doi:10.1007/978-81-322-2497-6_4